Findings of Research Misconduct

Notice is hereby given that ORI has taken final action in the following case:

Based on the admission of the Respondent, ORI found that Pratima Karnik, PhD, Assistant Professor, Department of Dermatology, Case Western Reserve University, engaged in research misconduct in research submitted to the NIH in grant application R01 AR062378.

ORI found that the Respondent engaged in research misconduct by plagiarizing significant portions from research grant application R21 AR061881, which she had reviewed for NIAMS, NIH, and inserting that text into her submitted grant application R01 AR062378-01. Respondent also plagiarized significant portions of text from the following scientific articles and one U.S. patent application available on the Internet:

  • BMC Med Genomics 4:8, 2011
  • J Am Col. Cardiol 52:117-123, 2008
  • Nature 457:910-914, 2009
  • J Autoimmun 29:310-318, 2007
  • U.S. Patent Application No. 20090047269 (published Feb. 19, 2009)
  • Toxicol Pathol 35:952-957, 2007
  • BMC Med Genomics 1:10, 2008
  • Open Systems Biology Journal 1:1-8, 2008
  • Endocrinology 146:4189-4191, 2005.

Dr. Karnik has entered into a Voluntary Settlement Agreement and has voluntarily agreed for a period of 2 years, beginning on July 22, 2013:

  1. To have her research supervised; Respondent agreed that prior to the submission of an application for U.S. PHS support for a research project on which her participation is proposed and prior to her participation in any capacity on PHS-supported research, Respondent shall ensure that a plan for supervision of her duties is submitted to ORI for approval; the supervision plan must be designed to ensure the scientific integrity of her research contribution; she agreed that she shall not participate in any PHS-supported research until such a supervision plan is submitted to and approved by ORI; Respondent agreed to maintain responsibility for compliance with the agreed upon supervision plan;
  2. That any institution employing her shall submit in conjunction with each application for PHS funds, or report, manuscript, or abstract involving PHS-supported research in which Respondent is involved, a certification to ORI that the content is free of plagiarized material, data provided by Respondent are based on actual experiments or are otherwise legitimately derived, and that the data, procedures, and methodology are accurately reported in the application, report, manuscript, or abstract; and
  3. To exclude herself voluntarily from serving in any advisory capacity to PHS including, but not limited to, service on any PHS advisory committee, board, and/or peer review committee, or as a consultant.

1 Comment »

  1. pom4pom said

    I noticed that falsified data is increasing these days, just wondering why most of them related to western blot results. someone care to comments. I am not a biochemist.

RSS feed for comments on this post · TrackBack URI

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: